Roberta Kahn

National Institutes of Health — United States

Neuroscience · Life Sciences

16h-index1.5kcitations25works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Neurotransmitter Receptor Influence on Behavior(16), Forensic Toxicology and Drug Analysis(7), Substance Abuse Treatment and Outcomes(5), Cannabis and Cannabinoid Research(3), Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes(3)

Publications25 total

A cholecystokinin B receptor antagonist and cocaine interaction, phase I study
CNS Neuroscience & Therapeutics·2018· 6 citedOpen Access
Bupropion for the treatment of methamphetamine dependence in non-daily users: A randomized, double-blind, placebo-controlled trial
Drug and Alcohol Dependence·2015· 67 cited
Transcriptome profiling and pathway analysis of genes expressed differentially in participants with or without a positive response to topiramate treatment for methamphetamine addiction
BMC Medical Genomics·2014· 17 citedOpen Access
Assessment of safety, cardiovascular and subjective effects after intravenous cocaine and lofexidine
Progress in Neuro-Psychopharmacology and Biological Psychiatry·2013· 5 cited
Effects of RG7652, a fully human mAb against proprotein convertase subtilisin/kexin type 9, on LDL-c: a Phase I, randomised, double-blind, placebo-controlled, single- and multiple-dose study
European Heart Journal·2013· 5 citedOpen Access
Safety of Atomoxetine in Combination With Intravenous Cocaine in Cocaine-Experienced Participants
Journal of Addiction Medicine·2012· 16 citedOpen Access
Topiramate for the treatment of methamphetamine addiction: a multi‐center placebo‐controlled trial
Addiction·2011· 107 citedOpen Access
Selegiline Transdermal System (STS) as an Aid for Smoking Cessation
Nicotine & Tobacco Research·2011· 23 citedOpen Access
Modafinil for the treatment of methamphetamine dependence
Drug and Alcohol Dependence·2011· 111 cited
A double-blind, placebo-controlled assessment of the safety of potential interactions between intravenous cocaine, ethanol, and oral disulfiram
Drug and Alcohol Dependence·2011· 19 citedOpen Access
Modafinil for the treatment of cocaine dependence
Drug and Alcohol Dependence·2009· 230 citedOpen Access
Multi-center trial of baclofen for abstinence initiation in severe cocaine-dependent individuals
Drug and Alcohol Dependence·2009· 91 cited
Modafinil for cocaine addiction: Multi-site clinical trial
European Psychiatry·2008· 1 cited
A double-blind, placebo-controlled trial of tiagabine for the treatment of cocaine dependence
Drug and Alcohol Dependence·2007· 59 cited
A double-blind, placebo-controlled trial of reserpine for the treatment of cocaine dependence
Drug and Alcohol Dependence·2007· 35 citedOpen Access
Bupropion for the Treatment of Methamphetamine Dependence
Neuropsychopharmacology·2007· 225 citedOpen Access
A preliminary randomized, double-blind, placebo-controlled study of the safety and efficacy of ondansetron in the treatment of methamphetamine dependence
The International Journal of Neuropsychopharmacology·2007· 131 citedOpen Access
Prevalence of abnormal liver-associated enzymes in cocaine experienced adults versus healthy volunteers during Phase 1 clinical trials
Contemporary Clinical Trials·2007· 7 cited
Poster Session I
Neuropsychopharmacology·2006· 5 citedOpen Access
Double-blind, placebo-controlled trial of selegiline transdermal system (STS) for the treatment of cocaine dependence
Drug and Alcohol Dependence·2006· 54 cited
page 1 of 2Next →

Frequent Co-authors

Ahmed Elkashef(20), Nora Chiang(11), A. Anderson(10), Shou-Hua Li(8), Frank J. Vocci(7), John D. Roache(6), Jan Campbell(6), William Haning(6), Tyson H. Holmes(5), Christopher Stock(5), Edwina Smith(4), Domenic A. Ciraulo(4), Eugene Somoza(4), Richard A. Rawson(4), Michael McCann(4), Joseph Mawhinney(4), Dennis Weis(4), Thomas F. Newton(4), Richard De La Garza(4), Christopher L. Wallace(4)